AmBisome and DaunoXome gain additional approvals.BOULDER, Colo.--(BUSINESS WIRE)--June 17, 1996--NeXstar Pharmaceuticals, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :NXTR) announced today that Norway has granted final marketing authorization for DaunoXome as a primary therapy for advanced AIDS-related Kaposi's sarcoma Kaposi's sarcoma (käp`əshē', kəpō`sē), a usually fatal cancer that was considered rare until its appearance in AIDS patients. . Fifteen countries have approved DaunoXome as primary therapy for advanced AIDS-related Kaposi's sarcoma. The Company is currently conducting clinical trials in several solid tumor indications as well as in lymphoma and leukemia. The Company also announced that Denmark has given final marketing approval to AmBisome, the Company's liposomal formulation of amphotericin B amphotericin B (ăm'fətĕr`ĭsĭn), antibiotic that halts the growth of several disease-causing fungi. Discovered in 1956, it is produced by bacteria of the genus Streptomyces. , for the treatment of confirmed and suspected life-threatening fungal infections in patients who have failed or are at risk for complications from conventional therapy. Previously, Denmark had approved AmBisome for the treatment of visceral leishmaniasis visceral leishmaniasis n. A chronic, often fatal disease occurring chiefly in Asia, caused by a protozoan parasite (Leishmania donovani) and characterized by irregular fever, enlargement of the spleen and liver, and emaciation. , a parasitic disorder. NeXstar Pharmaceuticals, Inc. is an integrated pharmaceutical company engaged in the discovery, development, manufacturing and marketing of products to treat life-threatening diseases. The Company currently markets two drugs, AmBisome and DaunoXome. The Company has headquarters in Boulder, Colorado; research, development and manufacturing facilities in San Dimas, California San Dimas is a city located in Los Angeles County, California. As of the 2004 census, the city had a total population of 36,200. History Don Palomares received a 15,000 acre (61 km) ; Antwerp, Belgium; Lakewood, Colorado, and Boulder; and marketing subsidiaries worldwide. CONTACT: NeXstar Pharmaceuticals Inc., Boulder Joseph Alper, 303/546-7717 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion